| AS | Active surveillance |
| PCa | Prostate cancer |
| GSU | Gleason score upgrade |
| LR | Low-risk |
| FIR | Favorable intermediate-risk |
| UIR | Unfavorable intermediate-risk |
| NCCN | National Comprehensive Cancer Network |
| CSM | Cancer-specific mortality |
| SEER | Surveillance, Epidemiology, and End Results Program |
| ISUP | International Society of Urological Pathology |
| AUA | American Urological Association |
| CSS | Cancer-specific survival |
| OS | Overall survival |
| PSA | Prostate-specific antigen |